Clinical trial
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior…
NCT00198471 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198471 |
|---|---|
| Title | Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment |
| Official title | An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitreous Detachment, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Vitrase |
| Enrollment | 10 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: